Sarcopenia in cirrhosis: From pathophysiology to interventional therapy
Authors:
Open Access
- 9 September 2024
- journal article
- review article
- Published by Elsevier in Experimental Gerontology
- Vol. 196, 112571
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 134 references indexed in Scilit:
- Quantifying Sex-Based Disparities in Liver AllocationJAMA Surgery, 2020
- Cholic acid and deoxycholic acid induce skeletal muscle atrophy through a mechanism dependent on TGR5 receptorJournal of Cellular Physiology, 2020
- Muscle Alterations Are Associated With Minimal and Overt Hepatic Encephalopathy in Patients With Liver CirrhosisHepatology, 2019
- Levocarnitine Use Is Associated With Improvement in Sarcopenia in Patients With Liver CirrhosisHepatology Communications, 2019
- Ammonia lowering reverses sarcopenia of cirrhosis by restoring skeletal muscle proteostasisHepatology, 2017
- Autophagy as a Potential Target for SarcopeniaJournal of Cellular Physiology, 2015
- Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathyHepatology, 2015
- The nutritional management of hepatic encephalopathy in patients with cirrhosis: International society for hepatic encephalopathy and nitrogen metabolism consensusHepatology, 2013
- Bone and Skeletal Muscle: Neighbors With Close TiesJournal of Bone and Mineral Research, 2013
- Nocturnal nutritional supplementation improves total body protein status of patients with liver cirrhosisHepatology, 2008